Works matching IS 10837159 AND DT 2013 AND VI 18 AND IP 3


Results: 19
    1
    2
    3
    4
    5

    Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials.

    Published in:
    Oncologist, 2013, v. 18, n. 3, p. 323, doi. 10.1634/theoncologist.2012-0334
    By:
    • Biessen, Diane A.J.;
    • Cranendonk, Merlijn A.;
    • Schiavon, Gaia;
    • Holt, Bronno;
    • Wiemer, Erik A.C.;
    • Eskens, Ferry A.L.M.;
    • Verweij, Jaap;
    • Jonge, Maja J.A.;
    • Mathijssen, Ron H.J.
    Publication type:
    Article
    6

    Analysis of Dermatologic Events in Vemurafenib-Treated Patients WithMelanoma.

    Published in:
    Oncologist, 2013, v. 18, n. 3, p. 314, doi. 10.1634/theoncologist.2012-0333
    By:
    • Lacouture, Mario E.;
    • Duvic, Madeleine;
    • Hauschild, Axel;
    • Prieto, Victor G.;
    • Robert, Caroline;
    • Schadendorf, Dirk;
    • Kim, Caroline C.;
    • McCormack, Christopher J.;
    • Myskowski, Patricia L.;
    • Spleiss, Olivia;
    • Trunzer, Kerstin;
    • Su, Fei;
    • Nelson, Betty;
    • Nolop, Keith B.;
    • Grippo, Joseph F.;
    • Lee, Richard J.;
    • Klimek, Matthew J.;
    • Troy, James L.;
    • Joe, Andrew K.
    Publication type:
    Article
    7
    8
    9

    Trastuzumab for the Treatment of Salivary Duct Carcinoma.

    Published in:
    Oncologist, 2013, v. 18, n. 3, p. 294, doi. 10.1634/theoncologist.2012-0369
    By:
    • Limaye, Sewanti A.;
    • Posner, Marshall R.;
    • Krane, Jeffrey F.;
    • Fonfria, Maria;
    • Lorch, Jochen H.;
    • Dillon, Deborah A.;
    • Shreenivas, Aditya V.;
    • Tishler, Roy B.;
    • Haddad, Robert I.
    Publication type:
    Article
    10
    11

    Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer.

    Published in:
    Oncologist, 2013, v. 18, n. 3, p. 281, doi. 10.1634/theoncologist.2012-0208
    By:
    • Lee, Michael S.;
    • Mamon, Harvey J.;
    • Hong, Theodore S.;
    • Choi, Noah C.;
    • Fidias, Panagiotis M.;
    • Kwak, Eunice L.;
    • Meyerhardt, Jeffrey A.;
    • Ryan, David P.;
    • Bueno, Raphael;
    • Donahue, Dean M.;
    • Jaklitsch, Michael T.;
    • Lanuti, Michael;
    • Rattner, David W.;
    • Fuchs, Charles S.;
    • Enzinger, Peter C.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas.

    Published in:
    Oncologist, 2013, v. 18, n. 3, p. 271, doi. 10.1634/theoncologist.2012-0404
    By:
    • Uronis, Hope E.;
    • Bendell, Johanna C.;
    • Altomare, Ivy;
    • Blobe, Gerard C.;
    • Hsu, S. David;
    • Morse, Michael A.;
    • Pang, Herbert;
    • Zafar, S. Yousuf;
    • Conkling, Paul;
    • Favaro, Justin;
    • Arrowood, Christy C.;
    • Cushman, Stephanie M.;
    • Meadows, Kellen L.;
    • Brady, John C.;
    • Nixon, Andrew B.;
    • Hurwitz, Herbert I.
    Publication type:
    Article
    19